Treatment for Pyelonephritis
For outpatient pyelonephritis, use oral fluoroquinolones (ciprofloxacin 500-750 mg twice daily for 7 days or levofloxacin 500 mg daily for 5 days) as first-line treatment when local fluoroquinolone resistance is <10%; for hospitalized patients, initiate IV therapy with fluoroquinolones, aminoglycosides with or without ampicillin, or extended-spectrum cephalosporins/penicillin-tazobactam, then transition to oral therapy once clinically improved. 1
Outpatient Management
First-Line Oral Therapy
- Ciprofloxacin 500-750 mg twice daily for 7 days or levofloxacin 500 mg daily for 5 days are the preferred oral agents 1
- These are the only antimicrobials recommended for oral empirical treatment of pyelonephritis 1
- Use fluoroquinolones only when local resistance rates are <10% 1
Alternative Oral Regimens (When Fluoroquinolones Inappropriate)
If fluoroquinolones cannot be used empirically:
- Administer a single IV dose of ceftriaxone or aminoglycoside first, then switch to oral therapy 2, 1
- Oral cephalosporins (cefpodoxime 200 mg twice daily for 10 days) can follow the initial parenteral dose 1
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days is acceptable only after an initial long-acting parenteral dose 1
Critical caveat: Never use nitrofurantoin, oral fosfomycin, or pivmecillinam for pyelonephritis—they do not achieve adequate tissue/parenchymal levels 2, 1
Inpatient Management
Initial IV Therapy
For patients requiring hospitalization:
- Fluoroquinolones (ciprofloxacin or levofloxacin) IV
- Aminoglycosides (with or without ampicillin)
- Extended-spectrum cephalosporins (ceftriaxone)
- Piperacillin-tazobactam 1
Transition Strategy
- Switch to oral therapy once the patient is clinically improved and can tolerate oral fluids 1
- High-dose oral beta-lactams for step-down: amoxicillin 1000 mg every 8 hours, amoxicillin-clavulanate 875-1000 mg every 8 hours, or cephalexin 1000 mg every 6 hours 2
Treatment Duration
5-7 days of treatment is as effective as 10-14 days for pyelonephritis, with no significant differences in clinical success, microbiological cure, or mortality 3. This applies to:
- Women with uncomplicated pyelonephritis: 5-7 days
- Men with febrile UTI: minimum 2 weeks recommended due to frequent prostatic involvement 1
- Pregnant women: 7-10 days total (parenteral then oral) 1
Special Populations
Pregnant Women
- Outpatient management possible if symptoms are mild and close follow-up feasible 1
- More severe cases require hospitalization
- Use imaging (ultrasound or MRI) to avoid radiation exposure 1
Men
- Minimum 2-week treatment duration, preferably with fluoroquinolones, as prostatic involvement is frequent 1
ESBL Concerns
- Use 1-2 doses of aminoglycoside as part of combination therapy when ESBL-producing organisms are suspected 2
- Single dose IV ceftriaxone before oral cephalosporin is effective for women with pyelonephritis 2
Diagnostic Requirements
Always obtain urine culture and antimicrobial susceptibility testing before starting antibiotics 1. Perform imaging (ultrasound initially) to exclude obstruction or stones, especially in patients with:
- History of urolithiasis
- Renal function disturbances
- High urine pH
- Persistent fever after 72 hours of treatment 1
Common Pitfalls
Avoid oral beta-lactams as monotherapy without initial parenteral dosing—they consistently show lower cure rates than fluoroquinolones or TMP-SMX when used for the same duration 2
Do not use standard-dose oral beta-lactams—if using them for step-down, use high doses to achieve adequate urinary levels 2
Resistance patterns matter—fluoroquinolone resistance exceeds 10% in many regions, particularly in recently hospitalized patients or those with recent quinolone exposure 4
Adjust empirical therapy as soon as susceptibility results are available to narrow spectrum and preserve broader agents for serious infections 4